Prospective Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jan 28, 2015; 21(4): 1292-1298
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1292
Figure 1
Figure 1 Probability of bleeding recurrence during the follow-up period (n = 132). A: Incidence of rebleeding with a mean follow-up period of 15 mo; B: Probability of rebleeding was significantly higher in the [non-steroidal antiinflammatory drug (NSAID) group than in the non-NSAID group (P < 0.01)]; C: Probability of rebleeding was significantly higher in the hemodialysis group than in the non-hemodialysis group (P < 0.01).
Figure 2
Figure 2 Probability of recurrent bleeding in patients with non-steroidal antiinflammatory drugs on admission (n = 41). The probability of rebleeding was higher in subjects continuing non-steroidal antiinflammatory drugs (NSAIDs) than in those discontinuing NSAIDs (P < 0.01).